Q3 2025 Results Presentation November 4, 2025 Forward-Looking Statements The information in this presentation highlights the key growth strategies, projections and certain assumptions for the company and its subsidiaries, including with respect to the benefits of acquisitions. Many of these highlighted statements and other statements not historical in nature are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Although the company believes th ...

Core Insights - Berkshire Hathaway Inc. reported an EPS of $9,378.93, exceeding estimates of $8,573.50, driven by strong performance in insurance and retail segments [2][6] - Operating earnings increased by 34% year-over-year, with net earnings attributable to shareholders rising to nearly $30.8 billion from $26.3 billion [3][6] - The company's stock is trading at attractive valuations, with a P/E ratio of 16.36 and a price-to-sales ratio of 2.74, following a 10.6% decline [4][6] Financial Performance - Revenue was reported at $94.97 billion, slightly below the estimated $95.62 billion, indicating resilience despite the shortfall [2] - The balance sheet is robust, featuring a cash reserve of $360 billion, a low debt-to-equity ratio of 0.19, and a high current ratio of 46.06, showcasing strong liquidity [5][6] Market Position - Berkshire Hathaway's unique structure and leadership differentiate it from competitors, which include large conglomerates and investment firms [1] - The company's strong financial position and strategic acquisitions contribute to its competitive edge in the market [1]

Core Thesis - Shutterstock, Inc. (SSTK) is identified as a compelling investment opportunity with a reward-to-risk ratio exceeding 2x, driven by its strong market position and strategic initiatives [2][7]. Revenue Generation - The company derives the majority of its revenue from subscriptions, one-time purchases, and licensing of stock media, controlling over 50% of the market and accounting for approximately 80% of total revenue [2]. Business Transformation - Despite facing long-term challenges in traditional media licensing, Shutterstock is transforming its business model by selling metadata to AI companies and expanding into customized content and advertising solutions [3]. AI Contracts - Contracts with AI companies, including OpenAI, are significant, contributing over $140 million annually and growing at a rate of around 30% per year [4]. Strategic Acquisitions - Recent acquisitions, such as GIPHY in 2021 and Envato in 2024, have diversified Shutterstock's offerings into audio, video, 3D, and enterprise-level creative services, aligning with its revenue target of $1.2 billion and adjusted EBITDA of $350 million by 2027 [5]. Financial Health - The company maintains a solid balance sheet with moderate leverage, stable shares outstanding, and rebounding free cash flow yielding mid-teens percentages post-acquisitions [6]. Merger Potential - The anticipated merger with Getty, expected to close by year-end, could unlock additional value, offering potential all-cash consideration of $28.85 per share, representing an upside of approximately 30% over the next 3-4 months [6]. Risk/Reward Profile - Even in downside scenarios, Shutterstock's stock is supported by strong fundamentals, including a 30% insider ownership stake, nearly 8% dividend yield, and a resilient AI-enhanced business model, presenting an attractive asymmetrical risk/reward profile [7].

Financial Data and Key Metrics Changes - Quarterly revenue was $9.7 billion, up 4.9% year over year, and adjusted diluted EPS was $9.5, up 17% [5][6] - Same store revenues for the quarter increased 7.7%, driven by growth in every business line [7] - Total gross profit increased 3.2%, with total vehicle GPU at $4,109, down $216 year over year [8][6] Business Line Data and Key Metrics Changes - New retail revenue grew 5.5% with units up 2.5%, while used retail revenue increased 11.8% driven by a 6.3% increase in unit growth [9][10] - Aftersales revenue increased 3.9%, with gross profit rising 9.1% and margins expanding to 58.4%, up 280 basis points year over year [13] - F and I revenue was up 5.7%, with F and I per retail unit reaching $18.47, up $20 year over year [12] Market Data and Key Metrics Changes - Domestic brand performance improved, while luxury brands performed the weakest year over year [9] - The UK market faced challenges with increased labor costs and regulatory pressures, but the company is improving productivity [14][37] Company Strategy and Development Direction - The company is focused on capturing market share and increasing customer loyalty, with a strategic emphasis on used vehicles and aftersales [6][11] - The acquisition strategy remains disciplined, targeting $2 billion in acquisition revenue for 2025, with a focus on high ROI opportunities [18][19] - The company aims to leverage its omnichannel platform to enhance customer experience and operational efficiency [14][28] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of cost control and productivity gains in navigating a mixed customer backdrop [6][22] - The company expects to finish strong in 2025 and continue building value through its ecosystem [6][21] - Management expressed confidence in the long-term growth potential, emphasizing the flexibility of their cash engine and acquisition strategy [18][28] Other Important Information - The company repurchased 5.1% of its outstanding shares this quarter, prioritizing share buybacks due to stock trading at a discount [16][27] - Driveway Finance Corporation reported $19 million in financing operations income for the quarter, with a net interest margin of 4.6% [25][26] Q&A Session Summary Question: EV sales and inventory management - Management noted that electrified vehicles made up 43% of total new car mix, with significant sales driven by manufacturer incentives [30][31] Question: UK market conditions and labor costs - Management discussed the impact of increased labor costs and regulatory changes, emphasizing self-help initiatives to improve productivity [36][37] Question: Used car market dynamics - Management highlighted opportunities in the used car market, particularly in the value auto segment, with a focus on sourcing directly from consumers [44][46] Question: M&A strategy and targets - Management reiterated the $2 billion acquisition target for the year, emphasizing a disciplined approach to acquisitions [81][82]

Core Insights - SRK Fund I, LP achieved a return of 46.94% in the first half of 2025, significantly outperforming the S&P 500 and Russell 2000, which returned 6.20% and -1.78% respectively [2][3] - Since its inception on May 1, 2018, the fund has appreciated 1200.66%, compared to 162.30% for the S&P 500 and 55.46% for the Russell 2000 [2][3] - The fund manager emphasizes the importance of long-term performance evaluation rather than short-term results [4] Portfolio Updates - **Innovative Solutions & Support (ISSC)**: Contributed significantly to the fund's performance with a 104% revenue increase and Ebitda margins reaching 35%. The company is expanding through strategic acquisitions and has increased its manufacturing capacity [6][7] - **ImmuCell Corporation (ICCC)**: Reported record first-quarter results with gross margins expanding to 42%. The company is targeting further growth and has received investigational use authorization for its product Re-Tain, which is pending FDA approval [8][9][10] - **Soléance (SLSN)**: Experienced a 53% revenue growth in the first half of the year despite lower margins due to onboarding costs. The company resolved litigation issues and uplisted to Nasdaq, which positively impacted its stock price [11] - **Sanuwave Health, Inc. (SNWV)**: Achieved 51% revenue growth without a national sales presence. The company has now established a national sales force and is pursuing debt refinancing options [12][13] Closing Thoughts - The strong returns in the first half of the year are viewed as a recovery from the previous year's poor performance. The fund has increased its cash reserves to capitalize on future investment opportunities [14]

Core Insights - Gibraltar Industries, Inc. (ROCK) is experiencing growth due to a strong backlog, disciplined portfolio simplification, strategic acquisitions, and a healthy balance sheet with solid cash flow generation [1][4][5] - The Agtech and Infrastructure segments are driving robust project-based activity, contributing positively to the company's performance [1][6][7] Company Performance - The total backlog for Gibraltar Industries increased by 43% year over year to $278 million, with Agtech backlog surging 71% [6][9] - The company reported an adjusted operating margin of 14.5% in Q2 2025, with a 300-basis-point margin expansion in the Infrastructure segment [9][10] - The company is focused on core markets after divesting its Renewables business, which is expected to enhance margin and cash flow performance [4][9] Strategic Initiatives - Gibraltar Industries is simplifying its portfolio by divesting non-core businesses and focusing on Building Products and Structures markets [4][5] - The company invested $208 million in targeted M&A to strengthen its presence in core markets, resulting in a 14% adjusted sales growth [5][6] - The implementation of 80/20 productivity initiatives and enterprise-wide business system conversions is expected to enhance operational efficiency and profitability [8][11] Industry Context - Other industry players like Armstrong World Industries, Owens Corning, and Masco Corporation are also benefiting from strategic acquisitions and strong liquidity positions [2][13][14][15] - Increased government funding and optimism regarding potential rate cuts by the Fed are fostering growth trends across the industry [2] Challenges - Gibraltar Industries faces challenges from housing softness, tariffs, margin strain, and funding risks, which may hinder growth prospects [3][11][12] - The company experienced margin pressure due to shifts in product and segment mix, with consolidated gross margin declining to 28.4% in Q2 2025 [11][12]

Core Insights - TMX VettaFi is positioning itself as a significant index partner through product expansion and strategic acquisitions [1] Company Strategy - The company is focusing on a strategy that includes both product expansion and making strategic acquisitions to enhance its market presence [1]

Core Insights - Humana Inc. (HUM) is positioned for growth due to increasing premiums, strategic acquisitions, an aging population in the U.S., and strong cash generation capacity [1] Membership and Premium Growth - Humana's membership base is expanding, particularly in Medicare Advantage and state-based programs, with Group Medicare Advantage membership increasing by 4.6% year over year and state-based contracts rising by 13.7% in Q2 2025 [2] - Premiums have shown consistent growth, with increases of 9.9% in 2022, 15.5% in 2023, 10.7% in 2024, and 8.6% in the first half of 2025 [2] - An anticipated increase of 175,000-250,000 members in state-based contracts is expected in 2025 [2] Segment Performance and Revenue Projections - Adjusted revenues in the insurance segment grew by 8.4% year over year in the first half of 2025, with projected revenues of at least $123 billion for the segment in 2025 [3] - The CenterWell segment's revenues increased by 8.9% year over year, with expectations of reaching at least $21.5 billion in 2025 [4] Strategic Expansion and Acquisitions - Humana is expanding its Medicaid presence with a new contract in Virginia, bringing its active presence to 10 states, with three additional states pending [5] - The company is pursuing strategic acquisitions and optimizing its portfolio by divesting non-core operations to enhance profitability [5] Financial Position - As of June 30, 2025, Humana held cash, cash equivalents, and investment securities totaling $21.7 billion, significantly exceeding its long-term debt of $12.6 billion [6] - The company has engaged in share repurchases worth $109 million in the first half of 2025, supported by strong operating cash flows [6] Earnings Performance - Humana has a strong earnings surprise history, exceeding estimates in three of the last four quarters with an average surprise of 9.6% [9] Challenges and Concerns - Operating expenses have been increasing, with year-over-year jumps of 11.5%, 14.9%, 12.5%, and 7.8% from 2022 to the first half of 2025 [10] - The benefit ratio deteriorated by 70 basis points year over year to 89.7% in Q2 2025, with expectations for the insurance segment's benefit ratio to be between 90.1% and 90.5% for 2025 [10] - Humana's debt-laden balance sheet is leading to increased interest expenses, which may pressure margins [10] Competitive Landscape - Competitors like Elevance Health, Inc. and The Cigna Group are also performing well, with Elevance Health's total operating revenues rising by 14.8% year over year in the first half of 2025 [11] - Cigna's adjusted revenues increased by 13% year over year in the same period, indicating strong market competition [12]

Core Insights - Fresenius Medical Care AG & Co. (FMS) is positioned for growth through strategic acquisitions and partnerships, despite concerns over rising costs [1][11] - The company's shares have increased by 13.3% year-to-date, contrasting with an 11.5% decline in the industry and a 14.4% decrease in the S&P 500 Index [1][7] Company Overview - Fresenius Medical has a market capitalization of $15.11 billion and is a leading provider of dialysis products and services for chronic kidney failure patients [2] - Earnings are expected to improve by 12.6% over the next five years, with the company beating earnings estimates in the last four quarters, averaging a surprise of 7.6% [2] Growth Drivers - **Strong Global Foothold**: The company has a significant presence in North America, EMEA, Asia Pacific, and Latin America, with 3,624 clinics serving over 308,000 patients [5][6] - **Strategic Acquisitions & Partnerships**: Recent acquisitions include NxStage Medical for $30 per share, with expected annual pre-tax savings of $80 million to $100 million [6][8] - **Home Dialysis Market Expansion**: The company has entered into distribution agreements in Japan and extended partnerships to enhance access to home hemodialysis [8] Financial Performance - FMS reported strong Q2 results, with earnings and revenues exceeding estimates, supported by pricing momentum and cost savings [9] - The FME25 transformation program has generated EUR 58 million in sustainable savings, with a target of EUR 1,050 million by the end of 2027 [10] Challenges - **Rising Costs**: The company faces increased labor costs of EUR 150 million to EUR 200 million and inflation-related costs of EUR 100 million to EUR 150 million, impacting short-term prospects [11] - **Treatment Volume Decline**: Overall treatments decreased due to divestitures, with a 0.2% decline in Same Market Treatment Growth in the U.S. [12] Future Estimates - The Zacks Consensus Estimate for 2025 revenues is $22.2 billion, indicating a year-over-year growth of 5.9%, while earnings are expected to grow by 34.3% to $2.23 per share [13]

Core Insights - Brown & Brown, Inc. (BRO) shares are trading at a discount compared to the Zacks Brokerage Insurance industry, with a forward price-to-earnings multiple of 19.69X, lower than the industry average of 19.79X and the Zacks S&P 500 Composite's 23.39X [1] - The company has a market capitalization of $29.98 billion and an average trading volume of 3.3 million shares over the last three months [1] Financial Performance - Brown & Brown's shares have declined by 11.9% over the past year, while the industry has seen a larger decline of 19.4% [3] - The Zacks Consensus Estimate for Brown & Brown's 2025 earnings per share indicates an 8.3% year-over-year increase, with revenues projected at $5.83 billion, reflecting a 21.3% year-over-year improvement [3] - Earnings have grown by 21.5% over the past five years, surpassing the industry average growth of 15.2% [4] Growth Strategy - The company has completed 702 acquisitions since 1993, leveraging strategic buyouts to capture market opportunities and enhance its product and service portfolio [8][12] - Brown & Brown has met its intermediate annual revenue goal of $4 billion, doubling its revenue in the last five years [11] Dividend and Capital Position - The company has a strong dividend history, having raised dividends for 30 consecutive years, with a five-year compound annual growth rate (CAGR) of 8.7% from 2019 to 2024 [8][14] - Brown & Brown maintains a robust liquidity position and an improving leverage ratio, ensuring strong cash conversion and effective cash deployment for acquisitions and shareholder dividends [13] Analyst Sentiment - The average price target for BRO, based on short-term estimates from 14 analysts, is $111.50 per share, suggesting a potential upside of 22.6% from the last closing price [9] - Positive analyst sentiment and favorable growth estimates position the company well for future growth [15]